Prudential Financial
ORGS

Prudential Financial’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Prudential Financial’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,100
Closed -$5.51K – 2775
2023
Q4 		$5.51K Sell
1,100
-800
-42% -$5.13K ﹤0.01% 2639
2023
Q3 		$11.5K Buy
+1,900
New +$17K ﹤0.01% 2583
2023
Q2 		– Sell
-2,755
Closed -$32.5K – 2732
2023
Q1 		$32.5K Buy
2,755
+260
+10% +$4.88K ﹤0.01% 2537
2022
Q4 		$48.7K Buy
2,495
+560
+29% +$9.54K ﹤0.01% 2494
2022
Q3 		$27K Buy
+1,935
New +$36.4K ﹤0.01% 2614

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BHB
Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Prudential Financial's ORGS Position: Q1 2024 in Review

Prudential Financial sold out of Orgenesis Inc. Common Stock (ORGS) in Q1 2024, closing a stake of 1,100 shares — an estimated $5.51K sold.

Prudential Financial first reported a position in ORGS in Q3 2022 and held it in 5 quarters. The position peaked at $48.7K in Q4 2022. 16 funds tracked by Wall St. Rank hold ORGS as of Q1 2024.

  • Prudential Financial reported no remaining Orgenesis Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Prudential Financial sold 1,100 Orgenesis Inc. Common Stock shares in Q1 2024, an estimated $5.51K.
  • Prudential Financial first reported a position in Orgenesis Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • Prudential Financial's Orgenesis Inc. Common Stock position peaked at $48.7K in Q4 2022.
  • 16 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q1 2024.

Based on Prudential Financial's 13F filing for Q1 2024, filed 14 May 2024.